The Relation Between Entecavir Dose and Therapeutic Effect in the Treatment of Hepatitis B Virus

doi 10.36468/pharmaceutical-sciences.spl.42

Full Text

Abstract

Available in

Date

Authors

Publisher

Indian Pharmaceutical Association - IPA

Related search

Letter: Distinct Hepatitis B Virus Relapse Rates After Discontinuing Tenofovir and Entecavir Therapy in Chronic Hepatitis B Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

A Comparison of 48-Week Treatment Efficacy Between Clevudine and Entecavir in Treatment-Naïve Patients With Chronic Hepatitis B

Hepatology International
Hepatology
2011English

Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation

Gastroenterology
HepatologyGastroenterology
2011English

Entecavir Treatment of Chronic Hepatitis D

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2012English

Constipation During Entecavir Treatment in Chronic Hepatitis B Patients: Two Cases Reports

Archives of Hepatitis Research
2017English

Transient Elastography Is Useful for Evaluating Hepatocellular Carcinoma Development During Entecavir Treatment of Chronic Hepatitis B Virus Infection

Gastroenterology, Hepatology and Endoscopy
2017English

Tenofovir and Its Potential in the Treatment of Hepatitis B Virus

Therapeutics and Clinical Risk Management
2009English

Potent Efficacy of Entecavir (BMS-200475) in a Duck Model of Hepatitis B Virus Replication

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Mutations in the Hepatitis B Virus Polymerase Gene Associated With Antiviral Treatment for Hepatitis B

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy